Elevance Health(ELV)
$429.69-0.21 (-0.05%)
ELV
Elevance Health financials statements
$429.69
At close:-0.21 (-0.05%)
Want to see ELV full AI Analyst Report?
Elevance Health (ELV) Ratios
2,918 Followers
Elevance Health Ratios
ELV's free cash flow for Q3 2026 was $1.00B. For the 2026 fiscal year, ELV's free cash flow was decreased by $-267.00M and operating cash flow was $1.27B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.24 | 1.10 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 1.24 | 1.10 | 0.00 | 0.00 | 0.00 |
| Cash Ratio | 0.48 | 0.43 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | 0.09 | 0.10 | 0.11 | 0.11 | 0.12 |
| Operating Cash Flow Ratio | 0.21 | 0.30 | 0.00 | 0.00 | 0.00 |
| Short-Term Operating Cash Flow Coverage | 3.11 | 2.68 | 4.30 | 4.76 | 4.46 |
| Net Current Asset Value | $ -52.74B | $ -54.12B | $ -69.52B | $ -66.42B | $ -61.33B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.28 | 0.23 | 0.23 | 0.24 |
| Debt-to-Equity Ratio | 0.76 | 0.79 | 0.64 | 0.67 | 0.64 |
| Debt-to-Capital Ratio | 0.43 | 0.44 | 0.39 | 0.40 | 0.39 |
| Long-Term Debt-to-Capital Ratio | 0.42 | 0.42 | 0.37 | 0.38 | 0.37 |
| Financial Leverage Ratio | 2.77 | 2.83 | 2.77 | 2.84 | 2.70 |
| Debt Service Coverage Ratio | 3.09 | 2.55 | 3.02 | 3.22 | 3.09 |
| Interest Coverage Ratio | 5.79 | 7.50 | 7.49 | 8.93 | 10.02 |
| Debt to Market Cap | 0.42 | 0.37 | 0.23 | 0.20 | 0.20 |
| Interest Debt Per Share | 156.16 | 145.52 | 112.20 | 104.02 | 97.74 |
| Net Debt to EBITDA | 2.46 | 2.33 | 1.77 | 1.65 | 1.80 |
| Profitability Margins | |||||
| Gross Profit Margin | 25.56% | 27.85% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | 4.07% | 5.14% | 5.10% | 5.40% | 6.34% |
| EBITDA Margin | 4.85% | 5.93% | 6.12% | 6.47% | 7.28% |
| Operating Profit Margin | 4.07% | 5.03% | 4.50% | 4.85% | 5.77% |
| Pretax Profit Margin | 3.37% | 4.47% | 4.50% | 4.85% | 5.77% |
| Net Profit Margin | 2.84% | 3.38% | 3.49% | 3.76% | 4.44% |
| Continuous Operations Profit Margin | 2.84% | 3.38% | 3.50% | 3.76% | 4.44% |
| Net Income Per EBT | 84.38% | 75.66% | 77.60% | 77.55% | 77.02% |
| EBT Per EBIT | 82.72% | 88.93% | 100.00% | 100.00% | 100.00% |
| Return on Assets (ROA) | 4.66% | 5.12% | 5.50% | 5.74% | 6.32% |
| Return on Equity (ROE) | 12.90% | 14.47% | 15.23% | 16.26% | 17.08% |
| Return on Capital Employed (ROCE) | 7.99% | 9.12% | 7.08% | 7.40% | 8.20% |
| Return on Invested Capital (ROIC) | 6.65% | 6.74% | 319.69% | 333.60% | 328.12% |
| Return on Tangible Assets | 6.91% | 7.82% | 8.16% | 8.66% | 9.83% |
| Earnings Yield | 7.28% | 6.96% | 5.45% | 4.79% | 5.45% |
| Efficiency Ratios | |||||
| Receivables Turnover | 13.07 | 13.54 | 9.59 | 9.76 | 10.32 |
| Payables Turnover | 8.68 | 8.10 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 38.81 | 33.88 | 39.31 | 36.28 | 35.38 |
| Asset Turnover | 1.64 | 1.51 | 1.57 | 1.52 | 1.42 |
| Working Capital Turnover Ratio | 59.52 | 260.59 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -14.14 | -18.10 | 38.06 | 37.40 | 35.38 |
| Days of Sales Outstanding | 27.93 | 26.95 | 38.06 | 37.40 | 35.38 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 42.07 | 45.05 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 27.93 | 26.95 | 38.06 | 37.40 | 35.38 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 19.34 | 24.94 | 34.59 | 35.00 | 34.31 |
| Free Cash Flow Per Share | 14.31 | 19.55 | 29.03 | 30.20 | 29.85 |
| Dividend Paid and CapEx Coverage Ratio | 1.62 | 2.10 | 3.00 | 3.53 | 3.82 |
| Capital Expenditure Coverage Ratio | 3.84 | 4.62 | 6.22 | 7.29 | 7.69 |
| Operating Cash Flow Coverage Ratio | 0.13 | 0.18 | 0.32 | 0.35 | 0.36 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.03 | 0.05 | 0.05 | 0.06 |
| Free Cash Flow Yield | 4.08% | 5.30% | 6.16% | 5.89% | 6.44% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 13.92 | 14.29 | 18.36 | 20.89 | 18.35 |
| Price-to-Sales (P/S) Ratio | 0.39 | 0.49 | 0.64 | 0.79 | 0.82 |
| Price-to-Book (P/B) Ratio | 1.77 | 2.08 | 2.80 | 3.40 | 3.13 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.50 | 18.87 | 16.25 | 16.99 | 15.53 |
| Price-to-Operating Cash Flow Ratio | 18.12 | 14.79 | 13.63 | 14.66 | 13.51 |
| Price-to-Earnings Growth (PEG) Ratio | -5.70 | 8.44 | 5.50 | -7.64 | 0.48 |
| Enterprise Value Multiple | 10.51 | 10.52 | 12.25 | 13.81 | 12.99 |
| Enterprise Value | 101.50B | 110.32B | 128.50B | 139.84B | 131.16B |
| EV to EBITDA | 10.51 | 10.52 | 12.25 | 13.81 | 12.99 |
| EV to Sales | 0.51 | 0.62 | 0.75 | 0.89 | 0.95 |
| EV to Free Cash Flow | 31.98 | 24.23 | 18.99 | 19.30 | 18.02 |
| EV to Operating Cash Flow | 23.66 | 18.99 | 15.94 | 16.65 | 15.68 |
| Tangible Book Value Per Share | 20.21 | 4.53 | 16.37 | 6.80 | 5.27 |
| Shareholders’ Equity Per Share | 197.84 | 177.42 | 168.64 | 151.01 | 147.91 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.16 | 0.24 | 0.22 | 0.23 | 0.23 |
| Revenue Per Share | 897.77 | 759.28 | 735.14 | 652.48 | 568.66 |
| Net Income Per Share | 25.53 | 25.68 | 25.69 | 24.56 | 25.26 |
| Tax Burden | 0.84 | 0.76 | 0.78 | 0.78 | 0.77 |
| Interest Burden | 0.83 | 0.87 | 0.88 | 0.90 | 0.91 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.76 | 0.97 | 1.35 | 1.40 | 1.37 |
Currency in USD

